5 Result(s)
within
C. Bergeron
Drug Resistance
-
Article
Open AccessTreatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP study
Clear cell sarcoma of the kidney (CCSK) is an uncommon paediatric renal tumour. Relapses occur in about 15% of the patients. Since detailed clinical information on relapsed CCSK is scarce, the current study ai...
-
Article
Open AccessLocalised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy
The purpose of this study was to evaluate the efficacy of low-dose chemotherapy in infants with localised and unresectable neuroblastoma (NB). All consecutive infants with localised NB and no N-myc amplification ...
-
Article
Open AccessTreatment of stage 4s neuroblastoma – report of 10 years' experience of the French Society of Paediatric Oncology (SFOP)
Stage 4s neuroblastoma (NB) is usually associated with a favourable outcome, despite a large tumour burden, as spontaneous regression frequently occurs. However, in some infants rapid disease progression can b...
-
Article
Open AccessLiquid-based cytology for primary cervical cancer screening: a multi-centre study
The aim of this six-centre, split-sample study was to compare ThinPrep fluid-based cytology to the conventional Papanicolaou smear. Six cytopathology laboratories and 35 gynaecologists participated. 5428 patie...
-
Article
Open AccessAdverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French Society of Pediatric Oncology
To assess the relevance of MYCN amplification and bone lesions in stage 4 neuroblastoma (NB) in infants aged <1 year, 51 infants with stage 4 NB were enrolled. Three groups of patients were defined according t...
